BJDXBluejay DiagnosticsBJDX info
$0.15info-1.97%24h
Global rank
Market cap$264.76K
Change 7d-31.65%
YTD Performance-87.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Bluejay Diagnostics (BJDX) Stock Overview

    Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

    BJDX Stock Information

    Symbol
    BJDX
    Address
    360 Massachusetts AvenueActon, MA 01720United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.bluejaydx.com
    Country
    🇺🇸 United States
    Phone Number
    844 327 7078

    Bluejay Diagnostics (BJDX) Price Chart

    -
    Value:-

    Bluejay Diagnostics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.149
    N/A
    Market Cap
    $264.76K
    N/A
    Shares Outstanding
    1.78M
    N/A
    Employees
    16.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org